Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)-Reference-Cited by-同舟云学术

Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)

Published:2021-11 Issue: Volume: Page:
ISSN:0272-2712
Container-title:Clinics in Laboratory Medicine
language:en
Short-container-title:Clinics in Laboratory Medicine

Author:

Sherman Amy C.,Desjardins Michaël,Baden Lindsey R.

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry

Reference82 articles.

1. Immunologic correlates of protection induced by vaccination;Plotkin;Pediatr Infect Dis J,2001

2. Interim results of a phase 1–2a trial of Ad26.COV2.S Covid-19 vaccine;Sadoff;New Engl J Med,2021

3. An mRNA vaccine against SARS-CoV-2 — preliminary report;Jackson;New Engl J Med,2020

4. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia;Logunov;Lancet,2020

5. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial;Zhu;Lancet,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates;Journal of Pharmacology and Experimental Therapeutics;2023-08-03

2. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients;Transplantation and Cellular Therapy;2023-06

3. Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2023-05

4. Humoral and T-cell–mediated immunity to SARS-CoV-2 vaccination in patients with liver disease and transplant recipients;Hepatology Communications;2023-03-17

5. Quantifying Antibody Persistence After a Single Dose of COVID ‐19 Vaccine Ad26. COV2 .S in Humans Using a Mechanistic Modeling and Simulation Approach;Clinical Pharmacology & Therapeutics;2022-12-09